Complementary and Alternative Medicines in Heart Failure: A Scientific Statement

A summary of the existing literature and clinical guidance from the American Heart Association

Complementary and alternative medicines (CAMs) are frequently used in the United States and are substantially less regulated than traditional pharmaceuticals. Because of the proliferation of evidence-based therapies for heart failure, particularly with reduced ejection fraction (HFrEF), clinicians need to know the existing evidence for the efficacy of CAMs — to the extent that it exists — and the potential for adverse drug interactions between traditional and alternative therapies in patients with HF. This recent AHA scientific statement summarizes the existing literature and provides guidance for clinicians caring for patients with HF.

Key points include:

Some evidence supports the efficacy of omega-3 polyunsaturated fatty acids in HF, which…

Reviewing Author

Frederick A. Masoudi, MD, MSPH, MACC, FAHA

Disclosures

Consultant/Advisory BoardBristol Myers Squibb; CPC Clinical Research

Grant/Research SupportNational Heart, Lung, and Blood Institute

Editorial BoardsUpToDate; American College of Cardiology Self-Assessment Program (SAP)

Leadership Positions in Professional SocietiesAmerican College of Cardiology (Chair, Innovations Committee)